Remove tag median-technologies
article thumbnail

Medicare savings won’t make a dent in healthcare costs

World of DTC Marketing

Still, in a JAMA study, the median net income (earnings) expressed as a fraction of revenue was significantly greater for pharmaceutical companies than nonpharmaceutical companies (13.8% New technologies are being developed that allow for virtual clinical trials and other cost-lowering development costs.

Drugs 222
article thumbnail

Immunocore’s Kimmtrak Gets FDA Approval as First Treatment for Rare Eye Cancer and First T Cell Receptor Therapeutic

XTalks

Kimmtrak has a price tag of $18,760 per vial, which amounts to a weekly dose. The median treatment time is about 23 weeks (or 5.3 Kimmtrak was the first molecule Immunocore developed using its proprietary ImmTAC technology platform. Kimmtrak led to a nearly 50 percent lower risk of death and a median overall survival rate of 21.7

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds December 2, 2022: A Randomized Controlled Trial of Mobile Health Intervention in Heart Failure and Diabetes: Lessons Learned (G. Michael Felker, MD, MHS)

Rethinking Clinical Trials

This study asks how can we better facilitate health behaviors in patients with chronic diseases and can we leverage technology? The median time to liberation in the HFNC group was 50 hours and the CPAP group was 43 hours. Medication adherence can be a barrier to effectiveness. HFNC was not noninferior to CPAP following extubation.

Trials 130
article thumbnail

Grand Rounds March 17, 2023: Remote Symptom Monitoring with Electronic Patient-Reported Outcomes (ePROs) in Oncology (Ethan Basch, MD, MSc)

Rethinking Clinical Trials

There were 766 patients enrolled in the study with a median follow up of 7 years. Compared to standard care, 31% more patients in the self-reporting arm experienced QOL benefits; 7% fewer patients in self-reporting arm visited the ER with durable effects throughout the study; and median survival was 5.2